This Funding Opportunity Announcement (FOA) invites researchers to submit applications for multi-disciplinary diagnostic strategies for rare diseases that combine machine-assistance, genomic analysis, and clinical consultation. Of particular importance, these strategies must be able to be adopted and performed at the primary or secondary care levels by front-line healthcare providers and be readily integrated into their clinical care workflow.
Deadlines:
-
Letter of Intent Due Date(s): 30 days prior to the application due date
-
Application Due Date(s): April 19, 2021
RFA-TR-21-008 Expiration Date April 20, 2021
In view of the goals of this FOA, applicants should assemble a multi-disciplinary team with expertise in medical informatics, genetic analysis, rare diseases, and front-line healthcare when preparing the application.
Direct cost funding support may not exceed $200,000 per year for the UG3 phase of awards and $300,000 per year for the UH3 phase awards.